Corvus Pharmaceuticals (CRVS) SEC Filings & 10K Form → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free CRVS Stock Alerts $1.96 +0.28 (+16.67%) (As of 05/8/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Recent Corvus Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/08/20247:28 PMCorvus Pharmaceuticals (Issuer)ORBIMED ADVISORS LLC (Reporting)OrbiMed Capital GP V LLC (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/08/20247:34 PMCorvus Pharmaceuticals (Issuer)Thompson Peter A. (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/08/20246:55 PMCorvus Pharmaceuticals (Subject)ORBIMED ADVISORS LLC (Filed by)Form SC 13D/A05/07/20244:16 PMCorvus Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/07/20244:19 PMCorvus Pharmaceuticals (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 05/03/20243:05 PMCorvus Pharmaceuticals (Filer)Form 424B505/01/20244:06 PMCorvus Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/01/20244:57 PMArcara Jeffrey (Reporting)Corvus Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/14/202412:31 PMCorvus Pharmaceuticals (Subject)SAMLYN CAPITAL, LLC (Filed by)Form SC 13G02/13/20245:27 PMCorvus Pharmaceuticals (Subject)MILLER RICHARD A MD (Filed by)Form SC 13G/A09/06/20236:39 PMCorvus Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/20/20234:03 PMCorvus Pharmaceuticals (Issuer)Thompson Peter A. (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/16/20233:54 PMCorvus Pharmaceuticals (Issuer)Grais Linda (Reporting)Form 4Statement of changes in beneficial ownership of securities (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: SPRO 10K Form CNTB 10K Form TPST 10K Form ALRN 10K Form MRNS 10K Form ANEB 10K Form BYSI 10K Form DERM 10K Form LFVN 10K Form VACC 10K Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:CRVS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
